Oligocopper‐Loaded Lipoic Acid Nanoparticles Promote Mitochondrial Protein Lipoylation for Augmented Cuproptosis Therapy

) achieved tumor inhibition rates of 74.32% and 84.87% in HepG2 and 4T1 tumor-bearing mice, respectively, demonstrating superior biosafety and significant clinical potential.